[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352292-105":59,"doc-detail-352292-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mhc-class-ii-and-beyond-complex-role-of-cd74-in-cancer","MHC Class II and Beyond - Complex Role of CD74 in Cancer","","Invariant chain, also known as CD74 on the plasma membrane, is classically involved in Major Histocompatibility Complex class II assembly, trafficking, and peptide loading in professional antigen presenting cells. Emerging work shows CD74 also regulates tumor–immune interactions by modulating antigen presentation, cytokine signaling, and immune evasion across diverse cancers. This review integrates evidence that CD74 acts as a “master regulator” connecting canonical chaperone functions to transcription regulation and MIF-dependent signaling, shaped by tumor microenvironmental context and influencing antitumor immunity and therapeutic outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mhc-class-ii-and-beyond-complex-role-of-cd74-in-cancer/352292/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mhc-class-ii-and-beyond-complex-role-of-cd74-in-cancer/352292.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the canonical function of CD74/invariant chain in antigen presentation?","Question",{"text":113,"@type":114},"CD74/invariant chain supports Major Histocompatibility Complex class II assembly, trafficking to endosomal/lysosomal compartments, and peptide loading so peptide–MHC-II complexes reach the cell surface.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does CD74 contribute to immune evasion in cancer?",{"text":118,"@type":114},"Dysregulated CD74 processing and MIF-CD74 signaling are linked to tumor immune evasion, and CD74 can shape the tumor immune microenvironment and antitumor immune responses.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is CD74 considered a therapeutic target or biomarker?",{"text":122,"@type":114},"CD74 is described as influencing both tumor biology and immune regulation, with elevated expression observed across many malignancies and functioning as a biomarker and target for cancer immunotherapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352292,1790178580,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nMHC Class II and Beyond: Complex Role of CD74 in Cancer Joanna Bandola-Simon  and Paul A. Roche *  \nExperimental Immunology Branch, National Cancer Institute, National Institutes of Health,  \nBethesda, MD 20892, USA; [joanna.bandola@nih.gov](joanna.bandola@nih.gov)  \n* [Correspondence: paul.roche@nih.gov](Correspondence: paul.roche@nih.gov); Tel.: +1-240-858-3355  \nHighlights  \nWhat are the main findings?  \n• CD74 links MHC class II antigen presentation with signaling and transcriptional regulation in cancer.  \n• Dysregulated CD74 processing and MIF-CD74 signaling contribute to tumor immune evasion.  \nWhat are the implication of the main findings?  \nAcademic Editor: Peter Van Endert  \nReceived: 12 December 2025  \nRevised: 5 January 2026  \nAccepted: 8 January 2026  \nPublished: 11 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n• CD74 shapes the tumor immune microenvironment and antitumor immune responses.  \n• CD74 represents a biomarker and therapeutic target for cancer immunotherapy.  \nAbstract  \nInvariant chain, also known as CD74 when expressed on the plasma membrane, is classically recognized for its role in Major Histocompatibility Complex class II molecule assembly, trafficking, and peptide loading in professional antigen presenting cells. However, recent studies implicate CD74 as a broader regulator of tumor–immune interactions, modulating antigen presentation, cytokine signaling, and immune evasion across diverse cancers. This review synthesizes emerging evidence that CD74 functions as a “master regulator” of antigen presentation in cancer, integrating its canonical chaperone role with its noncanonical role in transcription regulation and in signaling via macrophage migration inhibitory factor. We explore how tumor microenvironmental contexts redefine CD74 biology, influencing antitumor immunity and therapeutic outcomes.  \nKeywords: invariant chain; CD74; MHC class II; MIF; antigen presentation; cancer; immunotherapy  \n1. Introduction  \nAntigen presentation is central to both acquired and adaptive immune responses. Effective antitumor immunity depends on the presentation of tumor-derived peptides that T cells can only recognize when presented in the context of Major Histocompatibility Complex (MHC) molecules [1] . While broadly expressed MHC class I (MHC-I) molecules are involved in priming cytotoxic CD8+ T cells, MHC class II (MHC-II) molecules (whose expression is restricted primarily to professional antigen presenting cells (APCs)) play a crucial role in shaping CD4+ T helper responses, therefore indirectly orchestrating cytotoxic T cell responses. An essential player in MHC-II pathway is the chaperone molecule called Invariant chain (Ii), also known as CD74 . Primarily known for its role in antigen  \npresentation, Ii plays a critical role in adaptive immunity and therefore also in pathologies such as cancer.  \nBeyond its known role as a chaperone for MHC-II molecules, Ii has emerged as a multifunctional protein with relevance far beyond antigen presentation. Firstly, Ii ensures proper folding and transport of MHC-II molecules to endosomal/lysosomal antigen processing compartments for peptide loading, thereby enabling mature peptide–MHC-II (pMHC-II) complexes to reach the cell surface [2] . This tightly regulated process is essential for effective activation of CD4+ T cells and helps shape the quality and magnitude of antitumor immune responses.  \nSecondly, in recent years, CD74 has gained attention as a signaling molecule, particularly through its function as a high-affinity receptor for macrophage migration inhibitory factor (MIF) [3] . Engagement of CD74 by MIF initiates a signaling cascade that ultimately promotes cell survival and proliferation. This signaling axis has been implicated in chronic inflammation, autoimmunity, and in the","cbCaigCq5JaJwCwY","https://ap.wps.com/l/cbCaigCq5JaJwCwY","pdf",594065,17,"English","# Highlights\n## Main findings\n## Implications of the main findings\n# Abstract\n# Keywords\n# 1. Introduction\n# 2. Canonical Role of Ii in Antigen Presentation\n## 2.1. MHC-II Chaperone","[{\"question\":\"What is the canonical function of CD74/invariant chain in antigen presentation?\",\"answer\":\"CD74/invariant chain supports Major Histocompatibility Complex class II assembly, trafficking to endosomal/lysosomal compartments, and peptide loading so peptide–MHC-II complexes reach the cell surface.\"},{\"question\":\"How does CD74 contribute to immune evasion in cancer?\",\"answer\":\"Dysregulated CD74 processing and MIF-CD74 signaling are linked to tumor immune evasion, and CD74 can shape the tumor immune microenvironment and antitumor immune responses.\"},{\"question\":\"Why is CD74 considered a therapeutic target or biomarker?\",\"answer\":\"CD74 is described as influencing both tumor biology and immune regulation, with elevated expression observed across many malignancies and functioning as a biomarker and target for cancer immunotherapy.\"}]","MHC Class II and Beyond - Complex Role of CD74 in Cancer | PDF",1790098785,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b0ad7ce4a576db81bea26b481995e2a.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/605ff92e385db89b9a82e9ceeaecae09.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e219692c00235331f2163834488438b.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e322e90fce496740f718a7e7accafe0.webp",980,1385]